Zobrazeno 1 - 5
of 5
pro vyhledávání: '"Glykeria N. Daneva"'
Autor:
Panagiotis G. Adamopoulos, Konstantina Athanasopoulou, Michaela A. Boti, Georgios Dimitroulis, Glykeria N. Daneva, Panagiotis Tsiakanikas, Andreas Scorilas
Publikováno v:
RNA Biology, Vol 20, Iss 1, Pp 281-295 (2023)
Breast Cancer Gene 1 (BRCA1) is a tumour suppressor protein that modulates multiple biological processes including genomic stability and DNA damage repair. Although the main BRCA1 protein is well characterized, further proteomics studies have already
Externí odkaz:
https://doaj.org/article/eccf83b866a8452aaa6af2768cad1c22
Publikováno v:
BioMedInformatics, Vol 2, Iss 4, Pp 727-744 (2022)
In recent years, the advent of new experimental methodologies for studying the high complexity of the human genome and proteome has led to the generation of an increasing amount of digital information, hence bioinformatics, which harnesses computer s
Externí odkaz:
https://doaj.org/article/1bcc7fe30c294be48f3f795babc8b259
Publikováno v:
International Journal of Molecular Sciences, Vol 24, Iss 3, p 2387 (2023)
Although a plethora of DNA modifications have been extensively investigated in the last decade, recent breakthroughs in molecular biology, including high throughput sequencing techniques, have enabled the identification of post-transcriptional marks
Externí odkaz:
https://doaj.org/article/f0fce810cff344d9902f2394b54fa527
Autor:
Konstantina Athanasopoulou, Glykeria N. Daneva, Michaela A. Boti, Georgios Dimitroulis, Panagiotis G. Adamopoulos, Andreas Scorilas
Publikováno v:
Life, Vol 12, Iss 12, p 2010 (2022)
Deciphering cancer etiopathogenesis has proven to be an especially challenging task since the mechanisms that drive tumor development and progression are far from simple. An astonishing amount of research has revealed a wide spectrum of defects, incl
Externí odkaz:
https://doaj.org/article/5175ec2dc958440f998878fefeff4d80
Autor:
Konstantina, Athanasopoulou, Panagiotis G, Adamopoulos, Glykeria N, Daneva, Andreas, Scorilas
Publikováno v:
Apoptosis : an international journal on programmed cell death. 27(11-12)
BCL2 antagonist/killer (BAK) is a multidomain pro-apoptotic effector protein, encoded by the human BAK1 gene, which has emerged as a key checkpoint in the apoptotic machinery. Disassembly of BAK's tertiary structure, such as the truncation of the α1